The identication of current injecting trends in the Dublin and Midland Region through the application of syringe analysis methodology (MQI)
Bibliography: Interventions – Harm Reduction
Changes in the use of Melbourne’s Medically Supervised Injecting Room (MSIR) over the COVID-19 pandemic
In this bulletin, we update findings from a previous IDRS Bulletin that included information on the use of the North Richmond MSIR in 2019 to examine responses to the 2020 and 2021 IDRS surveys of people who inject drugs in order to examine any changes in MSIR use evident in the Melbourne IDRS samples over the COVID-19 pandemic (NDARC)
Developing international consensus to address high-risk drug use and overdose
Researchers in this study established an international consensus statement to guide the prevention, treatment, and management of high-risk substance use and overdose among youth (Recovery Research Institute)
Drug-related Deaths in Scotland in 2021
Statistics of drug-related deaths in 2021 and earlier years, broken down by age, sex, substances implicated in the death, underlying cause of death, and NHS Board and Council areas (National Records of Scotland)
Mapping prevention systems in the European Neighbourhood Policy area: a baseline for future monitoring and responses
This briefing describes the rationale and methodology of the prevention system mapping, presenting selected findings and highlighting key challenges encountered (EMCDDA)
Use, awareness and uptake of take-home naloxone among a sample of people who regularly inject drugs and use opioids in South Australia
The aims of this bulletin are to determine the extent to which a sample of people who regularly inject drugs who use opioids in Adelaide, SA (i) are aware of naloxone (2013-2021); (ii) are aware of take-home naloxone programs (2013-2021); (iii) have accessed naloxone (2020-2021); and (iv) have resuscitated peers or have been resuscitated by peers using naloxone (2020-2021) (NDARC)
Using the Global Drug Survey for harm reduction
This paper looks at the history of the GDS and the range of harm reduction tools that have been created using data from the survey (EMCDDA)
Expanding overdose prevention sites in Vancouver, Canada, has beneficial health impacts
Overdose prevention sites are a type of supervised injection service that are less regimented and have fewer barriers than traditional supervised injection services. The researchers in this study investigated the impact of this implementation in Vancouver on health outcomes (Recovery Research Institute)
Take Home Naloxone Programme
Annual report on the supply and use of Take Home Naloxone to reverse an overdose April 2020 – March 2021 (PHA Ireland)
Civil society monitoring of harm reduction in Europe 2021 data report
This is the third and last civil society-led C-EHRN Monitoring Report which is produced within the framework of the Operating Grant of the EU Health Programme1 (2018-2021). It is time to stand still and look at what we have achieved so far, what still needs to be done and where we see room for improvement (Correlation – European Harm Reduction Network)
National naloxone programme Scotland: annual Monitoring report 2019/20 and 2020/21 An Official Statistics publication for Scotland
This release by Public Health Scotland presents information on the number of take-home naloxone (THN) kits issued by the National Naloxone Programme in Scotland
Public Safety and Cannabis: Taking Stock of Knowledge Since Legalization: A Virtual Cannabis Policy Research Symposium Report
Summarizes six research papers on various public safety aspects of cannabis legalization, which were presented at the Public Safety and Cannabis: Taking Stock of Knowledge Since Legalization symposium in January 2022. This report highlights accumulated data and knowledge of the impacts of the Cannabis Act on public safety (CCSA)
Prisons and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide (EMCDDA)
Drug checking in Australia: how far do we have to go?
This presentation focused on drug checking or pill testing services, which have existed for over 50 years and now operate in more than 20 countries. Despite this long history, little research assessing feasibility or impact has been published in peer-reviewed journals (NDARC)
Needle Exchange Surveillance Initiative (NESI)
Prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs attending injecting equipment provision services in Scotland, 2008 to 2020 (Public Health Scotland)
Recreational settings and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide (EMCDDA)
Latest wastewater data reveal drug-taking habits in 75 European cities in a record 25 countries
Increases in detections of most drugs studied (EMCDDA)
Reducing Drug Deaths in London
London Assembly Health Committee
FACT SHEET: Addressing Addiction and the Overdose Epidemic
Drug overdose deaths have reached a historic high, devastating families and communities. More than 104,000 Americans died due to a drug overdose in the 12-month period ending in September 2021 (White House)
Universities should be more tolerant of drug use if they are to keep students safe from drug harms
A new report from the Higher Education Policy Institute, Illicit drug use in universities: zero tolerance or harm reduction?
New Zealand State of the Nation 2022
The latest edition of our annual report on how New Zealand is dealing with drugs and drug harm (NZDF)
Student drug use: reducing harm and tackling supply
Universities UK (UUK) has today announced new work, in partnership with Unite Students, GuildHE and Independent HE, to set out a common approach to reduce harms from drug use and to better tackle supply (UUK)
Shooting Up: infections among people who inject drugs in the UK
This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom (UK Government)
Evaluation of the Pharmaceutical Benefits Scheme subsidised take home naloxone pilot
This report presents the final evaluation findings, covering the pilot in NSW, SA and WA from commencement on 1 December 2019 up until 30 June 2021 (Australian Government)
Promising evidence that mobile engagement units can link hard-to-reach individuals with opioid use disorder to medication treatment
In this study, a mobile engagement unit was evaluated to see if this intervention would improve treatment utilization among a hard-to-reach population (Recovery Research Institute)
Experiences of overdose among people who inject drugs in the city of Toronto
In this report, we summarize what people who inject drugs in Toronto told us about their overdose experiences. We are interested in what happened at the time of their overdose and how others responded to their overdose (MAP)
Scoping project: A peer-based needle exchange service in London
This report explores the feasibility, acceptability, and practical considerations of developing a peer-based needle exchange service, with additional hepatitis C awareness and testing capacity, in Hackney (LJWG)
Report: Substance misuse related deaths in the criminal justice system
The Independent Advisory Panel on Deaths in Custody (IAPDC) and the Royal College of General Practitioners Secure Environments Group (RCGP SEG) have highlighted the need for a whole-systems approach to tackle substance misuse in the criminal justice system – in order to prevent substance misuse-related deaths amongst prisoners and those released back into the community (IAPDC)
From harm to hope: A 10-year drugs plan to cut crime and save lives
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system (Home Office)
Combining medication and adjunct services for opioid use disorder
Identifying cost-saving combinations that reduce risk of overdose and death (Recovery Research Institute)
Drug-related infectious diseases: health and social responses
This miniguide on responding to drug-related infectious diseases is one of a larger set, which together comprise Health and social responses to drug problems: a European guide 2021 (EMCDDA)
GDS 2021 Global Report
We wanted to focus on how COVID-19 changed people’s drug using behaviours especially with regard to alcohol, cannabis and cocaine, how people balance reducing harm and maximizing pleasure when using drugs, and whether microdosing has moved beyond those seeking to improve creativity and work performance to self-treatment for mental health issue (Global Drugs Survey)
Women’s Report
In February 2021, the Taskforce had a discussion about the particular issues facing women who use drugs and their families – download (Scottish Drug Deaths Taskforce)
Opioid overdose: An opportune time to link individuals to treatment?
he current study described initial outcomes of an assertive outreach method for opioid use disorder patients who had a recent nonfatal overdose, revealing its potential for enhancing treatment engagement and retention (Recovery Research Institute)
SAMHSA Extends the Methadone Take-Home Flexibility for One Year While Working Toward a Permanent Solution
The Substance Abuse and Mental Health Services Administration (SAMHSA) is extending the methadone take-home flexibilities for one year, effective upon the eventual expiration of the COVID-19 Public Health Emergency (SAMHSA)
Report and Recommendations of the NYSBA Task Force on Attorney Well-Being
NYSBA Attorney Well-Being Task Force, we expect this Report to be illuminating, sobering, and, ultimately galvanizing, acting as both a platform and a call to action (New York State Bar Association)
Improving outcomes among patients on medications for opioid use disorder is challenging, but incentivizing patients may be a path forward
In this study, researchers test a novel clinical intervention that incentivizes patients to adhere to treatment and remain abstinent from opioids (Recovery Research Institute)
Caught in the Crossfire
Health and human rights impacts of COVID-19 measures on people who use drugs in Indonesia and the Philippines (Harm Reduction International)
A Review of the Existing Literature and Evidence on Young People Experiencing Harms from Alcohol and Drugs in Scotland
This report provides a review of the existing literature and evidence base relating to alcohol and drug harms experienced by children and younger people (<25 years) in Scotland. It provides an up-to-date overview of the latest data on prevalence and harms related to alcohol and drug use among children and younger people (Scottish Government)
Safer drug consumption facilities: evidence paper
This paper highlights the evidence in support of safer drug consumption facilities (Scottish Government)
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 12
- Next Page »
